Welcome to Idorsia

Idorsia announced
Half Year Results
for 2018

When should we be celebrating our birthday?

Read about how Idorsia was born…

The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients.

Idorsia’s future success entirely depends on our people.

Idorsia's development compounds target a number of different diseases.

24 Jul 2018	Idorsia announces financial results for the first half 2018
19 Jul 2018	Invitation to Idorsia's half year financial results 2018 webcast and conference call
11 Jul 2018	Idorsia successfully completes the offering of new shares and the offering of convertible bonds thereby securing long-term funding for the development of its advancing pipeline

Event	When
9 Months 2018 Financial Results reporting*	October 23, 2018
Full-Year 2018 Financial Results reporting*	February 7, 2019
First Quarter 2019 Financial Results reporting*	April 18, 2019
Annual General Meeting 2019	May 3, 2019

*We will be in a silent period for 10 days ahead of the financial reporting.

IDIA SIX Swiss Exchange

At 17:31:25 CET

24.18 CHF

+0.04 (+0.17 %)

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91

4123 Allschwil

Switzerland